Familial thrombocytopenia flare-up following the first dose of mRNA-1273 Covid-19 vaccine
- PMID: 33580970
- PMCID: PMC8014325
- DOI: 10.1002/ajh.26128
Familial thrombocytopenia flare-up following the first dose of mRNA-1273 Covid-19 vaccine
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination.Am J Hematol. 2021 May 1;96(5):534-537. doi: 10.1002/ajh.26132. Epub 2021 Mar 9. Am J Hematol. 2021. PMID: 33606296 Free PMC article. No abstract available.
-
Immune Thrombocytopenia Following the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine.Isr Med Assoc J. 2021 Jun;23(6):341. Isr Med Assoc J. 2021. PMID: 34155844 No abstract available.
-
Platelet trends after Covid-19 vaccination in patients with chronic or persistent immune thrombocytopenia.Am J Hematol. 2021 Dec 1;96(12):E472-E474. doi: 10.1002/ajh.26366. Epub 2021 Oct 19. Am J Hematol. 2021. PMID: 34619804 Free PMC article. No abstract available.
-
COVID-19 vaccines and thrombosis with thrombocytopenia syndrome.Expert Rev Vaccines. 2021 Aug;20(8):1027-1035. doi: 10.1080/14760584.2021.1949294. Epub 2021 Jul 8. Expert Rev Vaccines. 2021. PMID: 34176415 Review.
-
Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis: A Review.JAMA Cardiol. 2021 Dec 1;6(12):1451-1460. doi: 10.1001/jamacardio.2021.3444. JAMA Cardiol. 2021. PMID: 34374713 Review.
Cited by
-
Immunogenicity and clinical features relating to BNT162b2 messenger RNA COVID-19 vaccine, Ad26.COV2.S and ChAdOx1 adenoviral vector COVID-19 vaccines: a systematic review of non-interventional studies.Futur J Pharm Sci. 2022;8(1):20. doi: 10.1186/s43094-022-00409-5. Epub 2022 Mar 26. Futur J Pharm Sci. 2022. PMID: 35368622 Free PMC article. Review.
-
Immune Thrombocytopenia in Previously Healthy Individuals Following SARS-CoV-2 Vaccination (COVID-19 Immunization): A Descriptive Research of 70 Instances With a Focus on Biomarkers, Predictive Outcomes, and Consequences.Cureus. 2022 Jul 1;14(7):e26480. doi: 10.7759/cureus.26480. eCollection 2022 Jul. Cureus. 2022. PMID: 35923492 Free PMC article. Review.
-
Two Cases of Immune Thrombocytopenia (ITP) Related to Viral Vector Vaccination ChAdOx1-S (AstraZeneca) and a Good Response after Thrombopoietin Receptor Agonist (TPO-RA) Therapy.Hematol Rep. 2024 Sep 27;16(4):585-592. doi: 10.3390/hematolrep16040057. Hematol Rep. 2024. PMID: 39449300 Free PMC article.
-
Case mistaken for leukemia after mRNA COVID-19 vaccine administration: A case report.World J Clin Cases. 2022 Nov 26;10(33):12268-12277. doi: 10.12998/wjcc.v10.i33.12268. World J Clin Cases. 2022. PMID: 36483810 Free PMC article.
-
COVID-19 Vaccination and the Rate of Immune and Autoimmune Adverse Events Following Immunization: Insights From a Narrative Literature Review.Front Immunol. 2022 Jul 5;13:872683. doi: 10.3389/fimmu.2022.872683. eCollection 2022. Front Immunol. 2022. PMID: 35865539 Free PMC article. Review.
References
-
- Jefferson T, Price D, Demicheli V, Bianco E, ERPfIVSSE P. Unintended events following immunization with MMR: a systematic review. Vaccine. 2003;21(25–26):3954‐3960. - PubMed
-
- Grimaldi‐Bensouda L, Michel M, Aubrun E, et al. A case‐control study to assess the risk of immune thrombocytopenia associated with vaccines. Blood. 2012;120(25):4938‐4944. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical